Sort by
Refine Your Search
-
: The successful candidate must have, and your application should clearly demonstrate that you meet the following: Essential Criteria: 2:1 Honours Degree, or equivalent, in Computer Science, Electrical/Electronic
-
in the discipline. For appointment at Senior Lecturer level, you will additionally have an established independent research programme, a sustained record of high-quality publications, evidence of
-
within the NIHR BioResource Centre Maudsley. The GLAD-MHG Omics Cohort, builds on the existing NIHR BioResource GLAD Study (>38,000 participants). The new programme will recruit an additional 12,000
-
an independent research programme. Evidence of scholarly activity, e.g. conference presentations, book or papers reviews. High level of analytical capability. Evidence of collaboration with and links to industry
-
’ application for Lecturer (Research and Education) should clearly demonstrate: A completed PhD (or very close to completion) in Accounting or a related discipline. An established programme of research activity
-
About the job: The principal aim of the Professor of Cancer Immunology is to provide leadership in the development and delivery of an innovative research programme in the field of Cancer Immunology
-
programme of research activity and dissemination of original, high-quality Actuarial Science or Finance research in line with accepted norms for Lecturer. A developing track record of high-quality peer
-
support a portfolio of complex clinical trials and data-enabled research activities across academic and industry partnerships. The post-holder will operate with a high degree of autonomy, working within a
-
challenges arising from environmental, technological, economic, and governance change. The role requires building a strong research profile through competitive funding, high quality publications, PhD
-
About the role To provide specialist technical expertise to support the development of a translational cancer research program focused on therapy resistance and lineage plasticity in prostate cancer